سابقه و هدف: ديسمنوره دربيش از50 درصدموارد بانشانههاي سيستميك مانند تهوع واستفراغ ، سردردو.. همراه است،كه سبب اختلال در كارو روابط اجتماعي زنان ميشود. با توجه به خاصيت ضدالتهابي رزماري، اين پژوهش با هدف مقايسه تأثيركپسول رزماري و مفناميك اسيد برعلائم همراه با ديسمنوره اوليه انجام شد.
مواد و روشها: اين مطالعه كارآزمايي باليني دوسوكور بر روي82 دانشجوي داراي ديسمنوره اوليه كه علائم سيستميك همراه داشتند در دانشگاه آزاد مشهد انجام شد. افراد داراي ديسمنوره متوسط وعلائم همراه طي دو سيكل بررسي شدند. نمونهها به صورت تصادفي به دو گروه رزماري(45 نفر) و مفناميك اسيد(45 نفر) تخصيص يافتند. در سه روزاول دوسيكل، هر 8 ساعت 250 ميليگرم از هردارو را دريافت كردند. جهت ارزيابي درد ازابزارمقياس ديداري درداستفاده شد. جهت تجزيه و تحليل دادهها از نرمافزارSPSS24 استفاده گرديد و 0/05>P معنيدار در نظر گرفته شد.
يافتهها: در دو سيكل مداخله نسبت به دو سيكل پايه ميانگين نمره شدت درد درگروه رزماري10/96±16/81 و مفناميك اسيد 12/80± 18/45 كاهش يافت و درهرگروه اختلاف معنيداري را نشان دادند (0/001>P)، اما بين دو گروه اختلاف معنيداري وجود نداشت (0/05
چكيده لاتين :
Background and purpose: Dysmenorrhea is associated with one or more systemic symptoms,
including nausea and vomiting, fatigue, diarrhea, low back pain, and headache in more than 50% of
the cases. These symptoms disrupt social communication in affected women. This investigation was
conducted to compare the effect of rosemary and mefenamic acid oral capsules on the symptoms of
primary dysmenorrhea.
Materials and methods: This randomized double-blind trial was conducted in 82 students with
primary dysmenorrhea in Islamic Azad University of Mashhad, Iran. Participants were studied in two
cycles for the symptoms of dysmenorrhea. They were randomly assigned into two groups; rosemary
(n=45) and mefenamic acid (n=45) using PASS software. They received 250 mg of medications in the
first three menstruation days 8-hourly. The visual analogue scale was used to determine the severity of
pain. Data were analyzed in SPSS V24.
Results: The mean scores for pain intensity significantly reduced in rosemary group and
mefenamic acid group compared to baseline scores (16.81±10.96 and 18.45±12.80, respectively) (P<0.001).
But, there were no significant differences between the two groups (P>0.05). Some symptoms, including
nausea in first cycle (P=0.01) and second cycle (P=0.02) and boredom in first cycle (P=0.02) and second
cycle (P=0.01) were found to be significantly different between the two groups. But, other symptoms
were not significantly different between the two groups (P>0.05).
Conclusion: Pain reducing effects of rosemary were similar to those of mefenamic acid and it
also reduced boredom and nausea. Medicinal drugs cause fewer side effects, therefore, rosemary could be
used as an alternative to mefenamic acid in management of dysmenorrhea.